Hepatic uptake transporters and docetaxel disposition in mice-letter

Clinical Cancer Research

Volumn 20, Issue 15, 2014, Pages 4167-

  Sparreboom, Alex ^a   Mathijssen, Ron H J ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; SOLUTE CARRIER ORGANIC ANION TRANSPORTER 1B2; ANTINEOPLASTIC AGENT; ORGANIC ANION TRANSPORTER; SLCO1B2 PROTEIN, MOUSE; TAXOID;

CANCER RESEARCH; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG UPTAKE; LETTER; MEDICAL LITERATURE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PUBLICATION; ANIMAL; BLOOD; COMPARATIVE STUDY; DBA MOUSE; KNOCKOUT MOUSE; MALE; MOUSE; PHYSIOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; MALE; MICE; MICE, INBRED DBA; MICE, KNOCKOUT; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; TAXOIDS;

EID: 84905454050     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-14-0949     Document Type: Letter

References (7)

1. De Graan A-J, Lancaster CS, Obaidat A, Hagenbuch B, Elens L, Friberg LE, et al. Influence of polymorphic OATP1B-type carriers on the disposition of docetaxel. Clin Cancer Res 2012;18:4433-40.
2. Hu S, Mathijssen RH, De Bruijn P, Baker SD, Sparreboom A. Inhibition of OATP1B1 by tyrosine kinase inhibitors: in vitro-in vivo correlations. Br J Cancer 2014;110:894-8.
3. Nieuweboer AJ, Hu S, Gui C, Hagenbuch B, Ghobadi Moghaddam-Helmantel I, Gibson AA, et al. Influence of drug formulation on OATP1B2-mediated transport of paclitaxel. Cancer Res 2014;74:3137-45.
4. Lee HJ, Leake BF, Teft W, Kim RB, Ho RH. Contribution of hepatic uptake transporters OATP1B1/OATP1B3 to the disposition of docetaxel. In: Proceedings of the Annual Meeting of the American Association for Cancer Research; 2014; Washington, DC. Philadelphia (PA): AACR; 2006. 3682.
5. Iusuf D, Hendrix JJ, Van Esch A, Van De Steeg E, Wagenaar E, Rosing H, et al. Human OATP1B1, OATP1B3 and OATP1A2 can mediate the in vivo uptake and clearance of docetaxel. Int J Cancer 2014 [Epub ahead of print].
6. Van De Steeg E, Van Esch A, Wagenaar E, Van Der Kruijssen CM, Van Tellingen O, Kenworthy KE, et al. High impact of Oatp1a/1b transporters on in vivo disposition of the hydrophobic anticancer drug paclitaxel. Clin Cancer Res 2011;17:294-301.
7. Van De Steeg E, Van Esch A, Wagenaar E, Kenworthy KE, Schinkel AH. Influence of human OATP1B1, OATP1B3, and OATP1A2 on the pharmacokinetics of methotrexate and paclitaxel in humanized transgenic mice. Clin Cancer Res 2013;19:821-32.